| Acquirer | Target | Price |
|---|---|---|
| Halyard Health | CORPAK Medsystems | $174 million |
| Synta Pharmaceuticals | Madrigal Pharmaceuticals | $60.9 million |
| Regeneron Pharmaceuticals Inc. | License to Cas-gene editing technology | $75 million |
| athenahealth | Arsenal Health | N/A |
| Stryker Corporation | SafeWire product portfolio | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
